Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Scaled Net Operating Assets : 0.66 (As of Mar. 2017)

View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aoxing Pharmaceutical Co's operating assets for the quarter that ended in Mar. 2017 was $55.39 Mil. Aoxing Pharmaceutical Co's operating liabilities for the quarter that ended in Mar. 2017 was $16.66 Mil. Aoxing Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2016 was $58.72 Mil. Therefore, Aoxing Pharmaceutical Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2017 was 0.66.

Aoxing Pharmaceutical Co Scaled Net Operating Assets Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Scaled Net Operating Assets Chart

Aoxing Pharmaceutical Co Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.53

0.61

0.65

0.96

0.69

Aoxing Pharmaceutical Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.77	0.62	0.66	0.60	0.66

Competitive Comparison of Aoxing Pharmaceutical Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aoxing Pharmaceutical Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Scaled Net Operating Assets falls into.

Aoxing Pharmaceutical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Aoxing Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2016 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Jun. 2016 )
=	(Operating Assets (A: Jun. 2016 )	-	Operating Liabilities (A: Jun. 2016 ))	/	Total Assets (A: Jun. 2015 )
=	(49.32	-	12.684)	/	53.041
=	0.69

where

	Operating Assets		(A: Jun. 2016 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	56.232	-	6.912
=	49.32

	Operating Liabilities		(A: Jun. 2016 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	38.156	-	0	-	25.472
=	12.684

Aoxing Pharmaceutical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2017 )
=	(Operating Assets (Q: Mar. 2017 )	-	Operating Liabilities (Q: Mar. 2017 ))	/	Total Assets (Q: Dec. 2016 )
=	(55.386	-	16.657)	/	58.724
=	0.66

where

	Operating Assets		(Q: Mar. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	62.466	-	7.08
=	55.386

	Operating Liabilities		(Q: Mar. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	44.38	-	0.1	-	27.623
=	16.657

Aoxing Pharmaceutical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217

Website

http://www.aoxingpharma.com

Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.

Executives

Wilfred Chow	officer: Chief Financial Officer	30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea	director	C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo	director, officer: Secretary	80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines